Amvuttra recommended by NICE for amyloidosis
Therapy is among the first to receive a positive draft recommendation under streamlined pilot process
Read More
Tag: amyloidosis
SMC approve Johnson & Johnson’s systemic light chain amyloidosis therapy
Newly diagnosed patients will become the first to access systemic light chain amyloidosis treatment in the UK
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
